Celldex Therapeutics (CLDX) Expected to Announce Earnings on Thursday
Celldex Therapeutics (CLDX) is scheduled to release its Q4 2025 earnings before market open on Thursday, February 26th, with analysts anticipating a loss of ($1.00) per share and revenue of $1.533 million. The company's stock opened at $23.00, trading within a 52-week range of $14.40 to $30.50, and holds a "Moderate Buy" consensus rating from analysts with an average price target of $41.56, despite some divergent views from firms like Barclays and Weiss. Institutional investors have also been active, with several increasing positions or buying new shares in CLDX during recent quarters.
https://www.marketbeat.com/instant-alerts/celldex-therapeutics-cldx-expected-to-announce-earnings-on-thursday-2026-02-19/